IPERTROFAN 40 150000ui (40mg) gastro-resistant film tablets medication leaflet

G04CX03 mepartricin • Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Other drugs used in benign prostatic hypertrophy

Mepartricin is a medication primarily used for the treatment of benign prostatic hyperplasia and certain inflammatory conditions of the urinary tract. It works by reducing inflammation and improving urinary flow.

The drug has anti-inflammatory and anti-estrogenic properties, making it useful in alleviating symptoms associated with prostate enlargement, such as difficulty urinating or the sensation of incomplete bladder emptying.

Mepartricin is administered orally, usually in capsule form, and the duration of treatment depends on the severity of the condition. It is important to follow the doctor's instructions to achieve the best results.

Adverse effects are rare but may include gastrointestinal disturbances or allergic reactions. Patients with hypersensitivity to this medication should avoid its use.

General data about IPERTROFAN 40 150000ui (40mg)

Substance: mepartricin

Date of last drug list: 01-07-2015

Commercial code: W04114002

Concentration: 150000ui (40mg)

Pharmaceutical form: gastro-resistant film tablets

Quantity: 20

Product type: original

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: DOPPEL FARMACEUTICI SRL - ITALIA

Holder: S.P.A. SOCIETA PRODOTTI ANTIBIOTICI SPA - ITALIA

Number: 11913/2019/01

Shelf life: 30 months